Literature DB >> 19401548

Whatever happened to immunotoxins? Research, and hope, are still alive.

David C Holzman.   

Abstract

Mesh：

Substances：

Year:  2009        PMID： 19401548     DOI： 10.1093/jnci/djp110

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN： 0027-8874            Impact factor:   13.506


× No keyword cloud information.
  4 in total

1.  Conformation and dynamics of biopharmaceuticals: transition of mass spectrometry-based tools from academe to industry.

Authors:  Igor A Kaltashov; Cedric E Bobst; Rinat R Abzalimov; Steven A Berkowitz; Damian Houde
Journal:  J Am Soc Mass Spectrom       Date:  2009-10-29       Impact factor: 3.109

2.  An evolved ribosome-inactivating protein targets and kills human melanoma cells in vitro and in vivo.

Authors:  Melissa C Cheung; Leigh Revers; Subodini Perampalam; Xin Wei; Reza Kiarash; David E Green; Aws Abdul-Wahid; Jean Gariépy
Journal:  Mol Cancer       Date:  2010-02-03       Impact factor: 27.401

Review 3.  Targeted toxins in brain tumor therapy.

Authors:  Yan Michael Li; Walter A Hall
Journal:  Toxins (Basel)       Date:  2010-11-01       Impact factor: 5.075

4.  Der p 1-based immunotoxin as potential tool for the treatment of dust mite respiratory allergy.

Authors:  Rodrigo Lázaro-Gorines; Juan Carlos López-Rodríguez; Sara Benedé; Miguel González; Cristobalina Mayorga; Lothar Vogel; Álvaro Martínez-Del-Pozo; Javier Lacadena; Mayte Villalba
Journal:  Sci Rep       Date:  2020-07-23       Impact factor: 4.379
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.